BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35494032)

  • 1. Oncolytic Activity of a Chimeric Influenza A Virus Carrying a Human CTLA4 Antibody in Hepatocellular Carcinoma.
    Yang H; Lei G; Sun F; Cheng J; Yan J; Zhang S; Yang P
    Front Oncol; 2022; 12():875525. PubMed ID: 35494032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Efficacy of an Oncolytic Influenza Virus Carrying an Antibody Against Programmed Cell Death 1 in Hepatocellular Carcinoma.
    Lei G; Li B; Yang H; Sun F; Li D; Yan J; Wang Y; Li R; Liu H; Zhang S; Li Y; Yang P
    Hum Gene Ther; 2022 Mar; 33(5-6):309-317. PubMed ID: 35018832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A recombinant influenza virus with a CTLA4-specific scFv inhibits tumor growth in a mouse model.
    Lei GL; Wang LP; Dong SH; Sun F; Cheng JX; Yang XL; Zhang SG; Wang XL; Wang XX; Yang PH
    Cell Biol Int; 2021 Jun; 45(6):1202-1210. PubMed ID: 33501754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Engineered Influenza a Virus Expressing the Co-Stimulator OX40L as an Oncolytic Agent Against Hepatocellular Carcinoma.
    Yang H; Lei G; Deng Z; Sun F; Tian Y; Cheng J; Yu H; Li C; Bai C; Zhang S; An G; Yang P
    J Hepatocell Carcinoma; 2024; 11():1-13. PubMed ID: 38223555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A chimeric influenza virus vaccine expressing fusion protein epitopes induces protection from human metapneumovirus challenge in mice.
    Chongyu T; Guanglin L; Fang S; Zhuoya D; Hao Y; Cong L; Xinyu L; Wei H; Lingyun T; Yan N; Penghui Y
    Front Microbiol; 2022; 13():1012873. PubMed ID: 38155756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A recombinant oncolytic influenza virus expressing a PD-L1 antibody induces CD8
    Sun F; Xu Y; Deng Z; Yang P
    Int Immunopharmacol; 2023 Jul; 120():110323. PubMed ID: 37207446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Recombinant Oncolytic Influenza Virus Carrying GV1001 Triggers an Antitumor Immune Response.
    Li C; Tian Y; Sun F; Lei G; Cheng J; Tian C; Yu H; Deng Z; Lu S; Wang L; Xiao R; Bai C; Yang P
    Hum Gene Ther; 2024 Jan; 35(1-2):48-58. PubMed ID: 37646399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncolytic Activity of a Novel Influenza A Virus Carrying Granulocyte-Macrophage Colony-Stimulating Factor in Hepatocellular Carcinoma.
    Penghui Y; Fang S; Ruilan W; Guanglin L; Hongjing G; Yueqiang D; Zhongpeng Z; Xiaolan Y; Zhaohai W; Shaogeng Z; Xiliang W
    Hum Gene Ther; 2019 Mar; 30(3):330-338. PubMed ID: 30205709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective efficacy of a novel recombinant influenza virus carrying partial human metapneumovirus F protein epitopes.
    Sun F; Lei G; Tian C; Bai Z; Bai C; Li Y; Deng Z; Yang H; Li C; Zhao Z; Niu Y; Yang P
    Virulence; 2023 Nov; ():2284515. PubMed ID: 37974334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced antitumor efficacy of a novel fiber chimeric oncolytic adenovirus expressing p53 on hepatocellular carcinoma.
    Chen W; Wu Y; Liu W; Wang G; Wang X; Yang Y; Chen W; Tai Y; Lu M; Qian Q; Zhang Q; Chen G
    Cancer Lett; 2011 Aug; 307(1):93-103. PubMed ID: 21504839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Chimeric Oncolytic Virus Vector for Improved Safety and Efficacy as a Platform for the Treatment of Hepatocellular Carcinoma.
    Abdullahi S; Jäkel M; Behrend SJ; Steiger K; Topping G; Krabbe T; Colombo A; Sandig V; Schiergens TS; Thasler WE; Werner J; Lichtenthaler SF; Schmid RM; Ebert O; Altomonte J
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30232179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of recombinant influenza A virus as a vector expressing respiratory syncytial virus fusion protein epitopes.
    Zhang P; Gu H; Bian C; Liu N; Li Z; Duan Y; Zhang S; Wang X; Yang P
    J Gen Virol; 2014 Sep; 95(Pt 9):1886-1891. PubMed ID: 24914066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Recombinant Antibody-Expressing Influenza Virus Delays Tumor Growth in a Mouse Model.
    Hamilton JR; Vijayakumar G; Palese P
    Cell Rep; 2018 Jan; 22(1):1-7. PubMed ID: 29298413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade.
    Ju F; Luo Y; Lin C; Jia X; Xu Z; Tian R; Lin Y; Zhao M; Chang Y; Huang X; Li S; Ren W; Qin Y; Yu M; Jia J; Han J; Luo W; Zhang J; Fu G; Ye X; Huang C; Xia N
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35688558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic Newcastle disease virus expressing a checkpoint inhibitor as a radioenhancing agent for murine melanoma.
    Vijayakumar G; Palese P; Goff PH
    EBioMedicine; 2019 Nov; 49():96-105. PubMed ID: 31676387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-specific oncolytic adenoviruses expressing granulocyte macrophage colony-stimulating factor or anti-CTLA4 antibody for the treatment of cancers.
    Du T; Shi G; Li YM; Zhang JF; Tian HW; Wei YQ; Deng H; Yu DC
    Cancer Gene Ther; 2014 Aug; 21(8):340-8. PubMed ID: 25034886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Third-generation oncolytic herpes simplex virus inhibits the growth of liver tumors in mice.
    Nakatake R; Kaibori M; Nakamura Y; Tanaka Y; Matushima H; Okumura T; Murakami T; Ino Y; Todo T; Kon M
    Cancer Sci; 2018 Mar; 109(3):600-610. PubMed ID: 29288515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An oncolytic vaccinia virus armed with anti-human-PD-1 antibody and anti-human-4-1BB antibody double genes for cancer-targeted therapy.
    Shi Z; Liu B; Huang C; Xie W; Cen Y; Chen L; Liang M
    Biochem Biophys Res Commun; 2021 Jun; 559():176-182. PubMed ID: 33945995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced antitumor efficacy of a novel oncolytic vaccinia virus encoding a fully monoclonal antibody against T-cell immunoglobulin and ITIM domain (TIGIT).
    Zuo S; Wei M; He B; Chen A; Wang S; Kong L; Zhang Y; Meng G; Xu T; Wu J; Yang F; Zhang H; Wang S; Guo C; Wu J; Dong J; Wei J
    EBioMedicine; 2021 Feb; 64():103240. PubMed ID: 33581644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic measles virus enhances antitumour responses of adoptive CD8
    Chen A; Zhang Y; Meng G; Jiang D; Zhang H; Zheng M; Xia M; Jiang A; Wu J; Beltinger C; Wei J
    Sci Rep; 2017 Jul; 7(1):5170. PubMed ID: 28701757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.